Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
JOINT STOCK COMPANY "KAZAKH RESEARCH INSTITUTE OF ONCOLOGY AND RADIOLOGY" has floated a tender for Purchase of Medicines, Amt: 9030269.55. The project location is Kazakhstan and the tender is closing on 19 Jan 2026. The tender notice number is 15993750-1, while the TOT Ref Number is 134337318. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines, Amt: 9030269.55
Deadline: 19 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 134337318
Document Ref. No.: 15993750-1
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 9030269.55
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Daunorubicin powder for solution for infusion, 20 mg | Ifosfamide - ifosfamide powder for solution for injection, 1000 mg | Irinotecan* concentrate for solution for infusion 40 mg/2 ml | Degarelix powder lyophilized for the preparation of solution for injection 80 mg complete with solvent | Irinotecan* concentrate for solution for infusion 100 mg/5 ml | Voriconazole - voriconazole tablets 200 mg | Special concentrate - Melphalan powder lyophilized for the preparation of solution for injection 50 mg | ifosfamide powder for solution for injection, 2000 mg
Documents
Procurement Documents for Kazakhstan
Access a comprehensive library of standard procurement documents specific to Kazakhstan. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Kazakhstan
Want To Bid in This Tender?
Get Local Agent Support in Kazakhstan and 60 More Countries.
View Tenders By
Sign in with Google